vs
Astrana Health, Inc.（ASTH）与Globe Life（GL）财务数据对比。点击上方公司名可切换其他公司
Globe Life的季度营收约是Astrana Health, Inc.的1.6倍（$1.6B vs $950.5M），Globe Life净利率更高（17.3% vs 0.7%，领先16.7%），Astrana Health, Inc.同比增速更快（42.9% vs 5.3%），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 4.1%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
Globe Life Inc.（股票代码：GL）是总部位于美国得克萨斯州麦金尼的金融服务控股公司，在纽约证券交易所上市，通过旗下全资子公司开展业务，主营人寿保险、年金产品及补充健康保险产品。
ASTH vs GL — 直观对比
营收规模更大
GL
是对方的1.6倍
$950.5M
营收增速更快
ASTH
高出37.5%
5.3%
净利率更高
GL
高出16.7%
0.7%
两年增速更快
ASTH
近两年复合增速
4.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $1.6B |
| 净利润 | $6.6M | $270.5M |
| 毛利率 | — | — |
| 营业利润率 | 1.9% | — |
| 净利率 | 0.7% | 17.3% |
| 营收同比 | 42.9% | 5.3% |
| 净利润同比 | 184.4% | — |
| 每股收益（稀释后） | $0.12 | $3.39 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHGL
| Q1 26 | — | $1.6B | ||
| Q4 25 | $950.5M | $1.5B | ||
| Q3 25 | $956.0M | $1.5B | ||
| Q2 25 | $654.8M | $1.5B | ||
| Q1 25 | $620.4M | $1.5B | ||
| Q4 24 | $665.2M | $1.5B | ||
| Q3 24 | $478.7M | $1.5B | ||
| Q2 24 | $486.3M | $1.4B |
净利润ASTHGL
| Q1 26 | — | $270.5M | ||
| Q4 25 | $6.6M | $266.1M | ||
| Q3 25 | $373.0K | $387.8M | ||
| Q2 25 | $9.4M | $252.7M | ||
| Q1 25 | $6.7M | $254.6M | ||
| Q4 24 | $-7.8M | $255.2M | ||
| Q3 24 | $16.1M | $303.0M | ||
| Q2 24 | $19.2M | $258.4M |
毛利率ASTHGL
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 26.1% | ||
| Q2 24 | — | 23.3% |
营业利润率ASTHGL
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 21.7% | ||
| Q3 25 | 2.0% | 31.5% | ||
| Q2 25 | 3.1% | 21.2% | ||
| Q1 25 | 3.3% | 21.4% | ||
| Q4 24 | 0.1% | 21.3% | ||
| Q3 24 | 5.9% | 26.3% | ||
| Q2 24 | 6.2% | 23.5% |
净利率ASTHGL
| Q1 26 | — | 17.3% | ||
| Q4 25 | 0.7% | 17.5% | ||
| Q3 25 | 0.0% | 25.6% | ||
| Q2 25 | 1.4% | 17.1% | ||
| Q1 25 | 1.1% | 17.2% | ||
| Q4 24 | -1.2% | 17.4% | ||
| Q3 24 | 3.4% | 20.8% | ||
| Q2 24 | 3.9% | 17.9% |
每股收益（稀释后）ASTHGL
| Q1 26 | — | $3.39 | ||
| Q4 25 | $0.12 | $3.28 | ||
| Q3 25 | $0.01 | $4.73 | ||
| Q2 25 | $0.19 | $3.05 | ||
| Q1 25 | $0.14 | $3.01 | ||
| Q4 24 | $-0.14 | $3.00 | ||
| Q3 24 | $0.33 | $3.44 | ||
| Q2 24 | $0.40 | $2.83 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $183.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $6.1B |
| 总资产 | $2.2B | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHGL
| Q1 26 | — | $183.8M | ||
| Q4 25 | $429.5M | $314.7M | ||
| Q3 25 | $463.4M | $62.8M | ||
| Q2 25 | $342.1M | $116.7M | ||
| Q1 25 | $260.9M | $134.1M | ||
| Q4 24 | $290.8M | $85.0M | ||
| Q3 24 | $350.3M | $100.5M | ||
| Q2 24 | $327.7M | $100.6M |
股东权益ASTHGL
| Q1 26 | — | $6.1B | ||
| Q4 25 | $779.3M | $6.0B | ||
| Q3 25 | $775.5M | $5.7B | ||
| Q2 25 | $765.5M | $5.4B | ||
| Q1 25 | $745.4M | $5.4B | ||
| Q4 24 | $712.7M | $5.3B | ||
| Q3 24 | $704.6M | $4.6B | ||
| Q2 24 | $678.9M | $5.2B |
总资产ASTHGL
| Q1 26 | — | — | ||
| Q4 25 | $2.2B | $30.8B | ||
| Q3 25 | $2.2B | $30.5B | ||
| Q2 25 | $1.4B | $29.8B | ||
| Q1 25 | $1.3B | $29.7B | ||
| Q4 24 | $1.4B | $29.1B | ||
| Q3 24 | $1.3B | $29.6B | ||
| Q2 24 | $1.3B | $28.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | — |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | — |
| 自由现金流率自由现金流/营收 | -0.6% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | -0.44× | — |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势，按日历期对齐
经营现金流ASTHGL
| Q1 26 | — | — | ||
| Q4 25 | $-2.9M | $350.6M | ||
| Q3 25 | $10.0M | $306.0M | ||
| Q2 25 | $90.9M | $307.9M | ||
| Q1 25 | $16.6M | $431.9M | ||
| Q4 24 | $-10.9M | $336.9M | ||
| Q3 24 | $34.0M | $340.6M | ||
| Q2 24 | $23.2M | $374.1M |
自由现金流ASTHGL
| Q1 26 | — | — | ||
| Q4 25 | $-6.0M | $330.1M | ||
| Q3 25 | $7.4M | $208.7M | ||
| Q2 25 | $89.5M | $295.0M | ||
| Q1 25 | $13.6M | $420.1M | ||
| Q4 24 | $-13.5M | $321.9M | ||
| Q3 24 | $31.7M | $311.3M | ||
| Q2 24 | $20.4M | $356.5M |
自由现金流率ASTHGL
| Q1 26 | — | — | ||
| Q4 25 | -0.6% | 21.7% | ||
| Q3 25 | 0.8% | 13.8% | ||
| Q2 25 | 13.7% | 19.9% | ||
| Q1 25 | 2.2% | 28.4% | ||
| Q4 24 | -2.0% | 22.0% | ||
| Q3 24 | 6.6% | 21.4% | ||
| Q2 24 | 4.2% | 24.8% |
资本支出强度ASTHGL
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 1.3% | ||
| Q3 25 | 0.3% | 6.4% | ||
| Q2 25 | 0.2% | 0.9% | ||
| Q1 25 | 0.5% | 0.8% | ||
| Q4 24 | 0.4% | 1.0% | ||
| Q3 24 | 0.5% | 2.0% | ||
| Q2 24 | 0.6% | 1.2% |
现金转化率ASTHGL
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | 1.32× | ||
| Q3 25 | 26.69× | 0.79× | ||
| Q2 25 | 9.65× | 1.22× | ||
| Q1 25 | 2.48× | 1.70× | ||
| Q4 24 | — | 1.32× | ||
| Q3 24 | 2.11× | 1.12× | ||
| Q2 24 | 1.21× | 1.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
GL
| Life premium | $853.2M | 55% |
| Health premium | $416.9M | 27% |
| Other | $289.5M | 19% |
